• Market share is expected to increase after commissioning of new plant in Surat.
• Post expansion capacity would be 7.6lakh Tonne.
• Realization increase in packaging board (growth of 4-5%) & coated paper (increased by around 1.5%).
Industry:
• Commodity & Energy price has certain impact.
• Raw material of Wood and Pulp has not much impact in the price.
• Global pulp price (mechanical) are down to 570-580 Rs, while prices of chemical pulp is 650&, while at peak it was 850$ (which was not sustainable)
• Global paper price depends on the other input cost and demand and supply scenario.
• This may vary with respect to country to country, with respect to demand.
• Demand in India, has been already back to pre-covid level.
Un-coated paper:
• Before wave 2 there was sudden drop in the price of un-coated paper. These prices were increased every month post wave 2.
• Right now price is back to pre-covid level ~62-63Rs kg.
• Further increase in energy price would lead to increase in price.
Packaging Board:
• Raw Material prices are increase, for which co. has increased the price of around 5% in Q2.
• While prices are increased further in Oct, to be realized in Nov.
Raw Material:
• Manufacturing cost increased by 8-9%, due to increase in coal prices, chemical prices and impact of commodities.
• Col dependence is 40% which is linkage for both the plants, while remaining energy is source from block liquor which is internally produced.
Margins:
• Most of raw material will now be from domestic sourcing.
• Margins are also impacted due to increase in sales at Sirpur plant, where the margins are lower, with respect to standalone level.
• Most of raw material will now be from domestic sourcing.
CAPEX:
• Capex spend was around 2000cr. JK Paper commission capex with the target of 12-14%.
• Standalone capacity utilization is around 110%, while sirpur plant capacity utilization is 77%.
Other:
• Interest expense have come down with re-payment of loan.
• Consolidated net debt of 2700cr would be the peak.
• With upcoming cash flow, co. would is targeting to repay debt of 250-300cr every year, and remaining would be utilized for different means.
For more discussion on Equity research and OI analysis
Alkyl Amines conducted the conference call for Q2 FY22
Here are the concall highlights 🧵👇
Business Updates:
• Started commissioning of Acetonitrile plants.
• Started new project for manufacturing higher need. This is about to commissioned by end of FY22.
• Mgmt expect H2 performance to be improved with respect to H1.
Logistics cost is impacting the export business
Margins:
• Decline of 10% in volume on QoQ basis, due to supply chain issue in pharma & agrochem. This was due to lower production of customer, as their certain other raw material from China is facing issue.
• While co. is unable to pass entire price hike to customer.
Grvita India India conducted the conference call for Q2 FY22
"Focus remains on optimizing the cost and bring margins to 10%"
Here are the concall highlights 🧵👇
Business Updates:
Revenue Share:
- Domestic revenue share: 64% (growth of 47%)
- Export revenue share: 36% (growth of 96%)
• Witnessed improvement in led, aluminium & plastics.
• Volume growth grew 30% YoY, while Value Added product contributed 45% of revenue.
Industry:
• 70% of informal sector would come down to 25% in the next 4-5 year, with recent government policy.
• Gravita being the only player in this segment would be highly beneficial.
Shalby conducted the concall today at 4:00 PM for Q1 FY22.
"Shalby is moving with exciting times with adapting various business lines, which will lead the growth in future"
Here are the Conference call highlights ☎️🧵
Business Updates:
• Majority of beds in month of May & April were converted to Covid beds.
• Average occupancy level increase to 60% this quarter.
• Shalby treated over 5,350 Covid-19 patients as compared to 776 in Q4 FY21.
Implant Business:
• Co. has recently acquired implant assets from Consensus Orthopedics in USA at USD 11.45 million to turnaround implant business by end of the next fiscal year.
• Plan to be breakeven in implant business by end of 2023
• In process of recruiting team members
Talbros Automotive conducted the concall today at 12:00 noon for Q1 FY22.
"Talbros in working hard to supply product to entire eco-system and entire value chain"
Here are the Conference call highlights ☎️🧵
Industry Updates:
• Supply Shortage and Chips Shortage is still creating issue in the industry.
• Automobile segment saw massive hit. However this quarter has seen pick both in domestic and export front.
• 7-10% of 2 Wheeler market is expected to convert in EV by 2025.
EV vs OEM:
• There is lot more disruption going on in the EV industry, hence any major investment in EV segment may turn risky.
• However there is lot more scope in India, as consumption is very less which. Hence even OEM segment will have increasing growth in India.
Kiri Industries conducted the concall today at 2:00 pm for Q1 FY22.
"Mgmt expect 30% sales growth in next quarter, with year end turnover to be around 1000cr (suppressed due to unexpected quarter)"
Here are the Conference call highlights ☎️🧵
Business Update:
• Impacted business due to covid
• Q2 FY has seen sharp increase in basic chemicals prices
• Passover of increase cost of sharp rise in raw material was not possible, resulting in decline margin
• While increase in legal cost of Dystar case impacted business
Industry Updates:
Domestic market was on standstill, especially in month of April and May. While currently market is picking up.
However domestic sales remain sluggish, resulted in impact in the textile business.